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This study investigated the heme oxygenase-1 (HO-1) and the endotoxin-induced uveitis (EIU) in diabetic streptozotocin (STZ)-
hyperglycemic rats. STZ-hyperglycemic rats had impaired levels of the enzyme HO-1 within the ciliary bodies if compared with
the nondiabetic rats. STZ-hyperglycemic rats also predisposed the eye to produce high levels of both the cytokines IL-1β and
CXCL8. Subsequent EIU further and signiﬁcantly (P<. 01) increased the cytokines production, an eﬀect partly prevented by
hemin treatment. Most importantly, hemin, an inducer of heme oxygenase expression and activity, recovered the huge number
of inﬁltrated polymorphonuclear leukocytes PMN within the ciliary bodies associated with STZ-hyperglycemic state and EIU
damage. Impairment of the stress-sensitive enzyme HO-1 in STZ-hyperglycemic rats increases and prolongs the inﬂammatory
response to EIU.
Copyright © 2006 Settimio Rossi et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Endotoxin-induceduveitis(EIU)isananimalmodelofacute
ocular inﬂammation. Cytokines, chemokines, and nitric ox-
ide (NO) have been reported to play important roles in pro-
moting the inﬂammation and cell injury of the ciliary bodies
in this pathology. Usually, this experimental pathology lasts
up to 72 hours and has similarities with the human pathol-
ogy [1].
Interestingly enough, the cell damage induced by the
EIU is strongly reduced by the heme oxygenase (HO)-1
[2]. HO-1 in injured tissues represents an adaptive and
defensive response to the inﬂammatory process [3], and
d u r i n gE I Ui th a sp r o t e c t i v ee ﬀects against the ocular in-
ﬂammation induced by lipopolysaccharide (LPS) by down-
regulating proinﬂammatory cytokines expression in normo-
glycemic rats [2].
Several studies have demonstrated that diabetes is a risk
factor for developing ocular diseases, increasing their preva-
lence and severity. Progression to severe eye pathologies with
loss of supporting structures is mediated by several factors,
including oxidative stress, free radicals, secretion of a broad
spectrum of inﬂammatory, and destructive mediators such
as cytokines (TNF-alpha, IL-1b, and IL-6), chemokines (IL-
8), and prostaglandin E2. This is caused by indirect eﬀects of
hyperglycemia [4].
The present study focuses on the likelihood that hyper-
glycemia in diabetes worsens the inﬂammatory response of
EIU by interfering with the HO-1 expression and activity.
We used LPS for the induction of EIU and streptozotocin
to induce diabetes, insulin 1.5 ± 0.5U/day for 8 days to
yield hyperglycemia (blood glucose levels of approximately
22mmol/L; 396mg/dl) (poor glycemic controlled rats).
MATERIALS AND METHODS
All experimental procedures and protocols used in this in-
vestigation were reviewed and approved by the Animal Care
and Use Committee of the Medical College of Naples. Exper-
iments were conducted in male Sprague-Dawley rats (four to
six months old and weighing on average 250g), diabetes was
induced according to the described procedures [5]. Partic-
ularly, streptozotocin was administered at 70mg/kg ip and
insulin (1.5 ± 0.5U/day ip) was applied to rats in order
to yield blood glucose levels of approximately 22mmol/L
(396mg/dl) for 8 days (poor glycemic controlled rats).2 Mediators of Inﬂammation
Table 1: Schematic representation of the experimental groups and measures done for each group.
Experimental groups Measures
Nondiabetic rats Diabetic rats (streptozotocin, 70mg/kg ip)
In each group the levels of
the following parameters
were measured: HO-1,
MPO, IL-1beta, CXCL8
Vehicle (saline, 0.1mL) Vehicle (saline, 0.1mL)
Vehicle + LPS (200μgi n0 . 1m L ) Vehicle + LPS (200μgi n0 . 1m L )
Hemin (50mg/Kg ip in 0.1mL, 1h prior to LPS) Hemin (50mg/Kg ip in 0.1mL, 1h prior to LPS)
Zn-PP (50μg/Kg ip, 6h before hemin)+LPS Zn-PP (50μg/Kg ip in 0.1mL, 6h before hemin)+LPS
InductionofEIU
Rats were injected in one footpad with 200μgo fl i p o p o l y s a c -
charide (LPS, Salmonella minnesota, Sigma, St Louis, Mo,
USA) in 0.1mL of sterile pyrogen-free saline [6].
Treatmentwithhemin
An intraperitoneal injection of 50mgkg−1 hemin (Fluka,
Buchs SG, Switzerland), an inducer of HO-1, was given 1
hour before LPS injection. The dose of hemin (50mgkg−1)
was chosen in accordance with previous studies in rats [2, 7,
8]. In addition zinc protoporphirin-IX (ZnPP-IX) was used
as inhibitor of the HO-1 at dose of 50μg/kg ip.
Experimentalgroups
RatswererandomlyallocatedtothegroupsshowninTable 1.
Nondiabetic and diabetic animals were sacriﬁced at 0, 6h,
12h, 18h, 24h, 48h, 72h (n = 6 for each time point) when
treated with vehicle alone and at the same time points when
added of LPS in all other groups.
Theiris-ciliarybodysamples
The iris-ciliary body (ICB) samples were dissected from the
eyes, collected, homogenized, and centrifuged to remove cel-
lular debris. Subsequently the frozen ciliary body tissues
were homogenized in a solution containg 0.5% hexa-decyl-
trimethyl-ammonium bromide dissolved in 10mM potas-
sium posphate buﬀer (pH 7) and centrifuged for 30min at
4,000 xg at 4◦C.
HO-1quantitation
ThisassaywasdonebyusinganELISAkitsuppliedbyStress-
genBiotechCorp(Victoria,BC,Canada).Thiskitshowssen-
sitivityof0.78ng/mLandrangesupto25ng/mLasfurnished
by Stressgen. An aliquot (100μl) of tissue supernatant was
used.
Myeloperoxidaseactivity
T h er e a c t i o nw a sp e r f o r m e da sp r e v i o u s l yd e s c r i b e d[ 9].
Data are reported as units of Myeloperoxidase (MPO) ac-
tivity per gram of tissue protein (U/g). A standard curve
was constructed with diﬀerent numbers of rats neutrophils
that were elicited into the peritoneal cavity at 4h in response
to application of 5mL thioglycollate. Pellets were subjected
to three cycles of freeze-thawing. Samples (100μl) were ob-
tained after a ﬁnal centrifugation at 13,000rpm for 30min
on a benchfuge. The MPO reaction was produced with a
PMN number ranging from 0 to 220 ×103, obtaining a lin-
ear relationship with the absorbance at 620nm following
the equation: A620 = 4.488× no. of PMN +33.74, with a
R2 = 0.98083. Data are reported as equivalent numbers of
PMN per mg of tissue.
CytokinequantitationbyELISA
Tissue IL-1β levels in tissue homogenates (50μl) were de-
termined using a commercially available ELISA speciﬁc for
the rats cytokine, purchased from R&D Systems (Abingdon,
UK). Brieﬂy, tissue supernatant aliquots (50μl) were assayed
forIL-1β andcomparedtoastandardcurveconstructedwith
0-1ng/mL of the standard cytokine. The ELISA showed neg-
ligible (<1%) cross-reactivity with several murine cytokines
and chemokines (data as furnished by manufacturer). A
similar procedure was followed for determination of the
chemokine CXCL8 by ELISA (R&D Systems, UK) and used
according to the manufacturer instructions.
Drugs
STZ, ZnPP-IX were purchased from Sigma-Aldrich (Milan,
Italy); this latter compound was dissolved in saline (vehicle).
Statisticalanalysis
A l lv a l u e sa r ee x p r e s s e da sm e a n± S E Mo fn u m b e r( n)o f
rats for the in vivo experiments. Statistical analysis was as-
sessed either by Student’s t test (when only two groups were
compared) or one-way ANOVA followed by Dunnett’s test
(more than two experimental groups). A probability P value
less than 0.05 was considered signiﬁcant to reject the null hy-
pothesis.
RESULTS
STZ-hyperglycemicrats
Blood glucose averaged 6.2 ± 0.1mmol/l in basal conditions
and rose to 23.0 ± 2mmol/L 15 hours after STZ adminis-
tration. In STZ-rats, a repeated intraperitoneal intravenousSettimio Rossi et al 3
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Figure 1: STZ-diabetes and HO-1 levels following EIU. Rats were
treated ip with vehicle saline; LPS alone (nondiabetic); LPS+STZ
(diabetic), or hemin (50mg/kg 1h prior to LPS or LPS+STZ). Sig-
niﬁcance is expressed as •P<. 05 versus vehicle saline nondiabetic
rats; ∗P<. 05 and ∗∗P<. 01 versus LPS nondiabetic rats; ◦P<. 05
and ◦◦P<. 01 versus LPS+hemin nondiabetic rats.
infusion of regular insulin (1.5 ± 0.5U/day) was given
a n da d j u s t e dt oy i e l db l o o dg l u c o s el e v e l so fa p p r o x i m a t e l y
22mmol/L (396mg/dl) for 8 days. Serum sodium and potas-
sium concentrations and body weight did not signiﬁcantly
change after STZ-treatment (data not shown).
HO-1quantitation
In vehicle treated nondiabetic rats ciliary bodies HO-1 level
was not appreciable as evidenced by HO-1 ELISA over the
time (Figure 1). HO-1 level signiﬁcantly (P<. 05) increased
after EIU in nondiabetic rats treated with LPS starting 12h
post-LPS, reaching a value of 788 ± 42% respect to baseline
12h later (P<. 001). Administration of hemin prior to EIU
produced a further and signiﬁcant increase of HO-1 at all
the times (Figure 1). ZnPP-IX+hemin prior to LPS strongly
restored the values of HO-1 detected following the LPS alone
(data not shown).
HO-1 was already present in ICB after 8 days of poor
glycemic control (Time 0 saline, +83.3 ± 11% versus time 0
nondiabetic; see Figure 1). This HO-1 level remained almost
steady even 24h later (data not shown). Interestingly, the
treatment with LPS increased the levels of HO-1 starting 6h
after the injection with a peak value at 24h time point. This
increase was 68 ± 4% lower than the incremental expression
seen in nondiabetic rats at same 24h time (P<. 001). LPS-
induced HO-1 expression felt within the following 24 and
48 hours (Figure 1). Although hemin treatment, the inducer
of HO-1, increased (P<. 01) all the ﬁgures seen in STZ-
diabetic rats (Figure 1), the maximum increases in these rats
were lower than those observed in LPS-induced nondiabetic
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Figure 2: Myeloperoxidase activity (MPO) in ciliary body. Rats
treated as described in Figure 1 had ciliary body collected at the
end of the 24h endotoxin-induced uveitis and MPO activity deter-
mined. Values are mean ± SEM of n = 6 rats per group. Signiﬁ-
cance is expressed as •P<. 05 versus vehicle saline nondiabetic rats;
∗P<. 05 and ∗∗P<. 01 versus LPS nondiabetic rats; ◦P<. 05 and
◦◦P<. 01 versus LPS+hemin nondiabetic rats.
ratssubjectedtothesametreatmentandcomparedatsimilar
time points. This eﬀect on the HO-1 levels started 18h after
LPS and lasted 72h (Figure 1). ZnPP+hemin did not modify
the levels observed in the LPS-diabetic condition alone (data
not shown). Therefore hyperglycaemia impairs the levels of
HO-1 within the ciliary body, a situation patially restored by
hemin.
PMNassociatedEIUdamage
In nondiabetic rats EIU was paralleled by increase in MPO
activity in the ciliary bodies versus control rats (ie, saline,
time 24h, 93 ± 14 equivalent PMN number/mg tissue; LPS
time 24h, 640 ± 30 equivalent PMN number/mg tissue, P<
.001).ThisLPS-inducedMPOvaluedecreasedwithinthefol-
lowing 24 and 48 hours (Figure 2). Administration of hemin
produced an attenuation in MPO activity as measured 24h
post-LPS and at other time points (Figure 2). This attenua-
tion in MPO activity was absent in the rats treated with the
hemin + ZnPP (data not shown).
Control STZ-hyperglycemic rats showed increase in
MPOactivitywithrespecttonondiabeticcontrolratsadmin-
istered with same saline (saline STZ-rats, 152±28 equivalent
PMN number/mg tissue; saline nondiabetic, 93 ± 14 equiv-
alent PMN number/mg tissue, P<. 05). LPS procedure fur-
ther increased the values of MPO up to 24h while decreasing
later(Figure 2).TheMPOvaluesinSTZ-ratswerestillhigher
than those in normoglycemic rats (Figure 2)c o m p a r e da t
samepoints.AdministrationofLPS+heminproducedMPO4 Mediators of Inﬂammation
levels still higher than the nondiabetic values measured at
any time considered post-LPS (Figure 2). However the as-
sociation with ZnPP-IX reduced the MPO values almost at
same values of STZ-EIU rats (data not shown). Hypergly-
caemic diabetes produces a worsening of the MPO activity
withinICBfollowinguveitis.BypotentiatingtheHO-1path-
way with hemin this MPO activity is almost restored to val-
ues of the nondiabetic condition.
Cytokinelevelsintheciliarybodies
At 24h time point ciliary bodies IL-1β and CXCL8l e v e l s
were slight appreciable in control nondiabetic rats, (saline,
22 ± 3pg/mg tissue and 100 ± 26pg/mg tissue, resp). LPS-
induced uveitis showed 24h levels of the IL-1β and CXCL8
up to values of 210 ± 21pg/mg tissue and 590 ± 34pg/mg,
respectively. The important issue is that the tissue levels of
these cytokines after 48h and 72h were decreased (Figure 3).
Hemin prior to the LPS produced a signiﬁcant reduction in
IL-1β and CXCL8 levels within the tissue (Figure 3). This re-
ductionwasabsentintheratstreatedwiththehemin+ZnPP-
IX (data not shown).
STZ-hyperglycemia predisposed the eye to produce high
levels of both the cytokines IL-1β and CXCL8 as assayed
24h after saline injection (ie, 83 ± 14pg/mg tissue and
198 ± 30pg/mg tissue, resp). Subsequent EIU further and
signiﬁcantly (P<. 01) increased the cytokines produc-
tion (Figure 3). Hemin decreased the cytokines production
with levels being still higher than those in nondiabetic rats
(Figure 3). The association of ZnPP-IX and hemin report the
cytokine levels to almost the values assayed in the rats sub-
jected to STZ treatment (data not shown).
Ciliary IL-1β and CXCL8 increase after EIU in nondia-
betic LPS-rats and much more following the concomitance
of diabetes. The inducer of the HO-1 activity hemin protects
theeyefromthereleaseofcytokinesbothinnormoglycaemic
and hyperglycaemic states. However the eﬀect of this com-
pound in this latter circumstance is lower, in agreement with
results shown on the fact that the endogenous HO-1 is im-
paired by the diabetes.
DISCUSSION
This study shows that 8 days of hyperglycemia or poor
glycemic control in STZ-diabetic rats lead to more persis-
tent inﬂammation and tissue damage following EIU. The
inﬂammatory response was evidenced here by higher and
more prolonged production of cytokines and chemokines
as well as PMN inﬁltration into the ciliary bodies of STZ-
hyperglycemic rats compared with nondiabetic rats. In spite
of several reports in humans and animals addressing (i)
the stimulation of an inﬂammatory response and release of
inﬂammatory mediators by diabetes [10] and (ii) the im-
portance that this response has on the severity of diﬀerent
pathologies [11] the present study is noteworthy the ﬁrst re-
port showing that this condition also enhances the inﬂam-
matory response during the EIU.
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Figure 3: HO-1 induction reduces cytokine levels in the ciliary
body. Tissues at each time point of the EIU procedure were col-
lectedfromn = 6ratsforeachgroupandwereanalysedforIL-1β or
CXCL8 determined by ELISA. Signiﬁcance is expressed as •P<. 05
versus vehicle saline nondiabetic rats; ∗P<. 05 and ∗∗P<. 01 ver-
sus.LPS nondiabetic rats; ◦P<. 05and ◦◦P<. 01 versus LPS+hemin
nondiabetic rats.
This study also shows the likelihood that STZ-hypergly-
cemia causes increased and prolonged inﬂammation during
EIU by impairing the expression of the enzyme HO-1 within
the ciliary tissues. HO-1 in injured tissues represents an
adaptive and defensive response to the inﬂammatory process
[3], and during EIU it has protective eﬀects against the oc-
ular inﬂammation induced by lipopolysaccharide by down-
regulating proinﬂammatory cytokines expression in normo-
glycemic rats [2]. Both LPS-induced ocular response and the
expression of the HO-1 enzyme seem to appear earlier in theSettimio Rossi et al 5
STZ-hyperglycemic rats than in normoglycemic ones. They
are already and signiﬁcantly present in rat ciliary bodies in
basal conditions, 6 hours after LPS, increased 18 hours later
by reaching the maximum level, and felt within the follow-
ing 24 and 48 hours. So, diabetes by inducing per se oxidative
stress anticipates the insurgence of LPS-induced events, both
inﬂammatory and HO-1 response. Noteworthy, pathophysi-
ological stimuli that increase oxidative stress upregulate HO-
1[ 12, 13]. In addition to the facts expressed not so far, the
evidence that there is diﬀerence between the levels of HO-1
found at the peak of the inﬂammatory response in nondia-
betic rats and those in STZ-rats, both subjected to EIU, ar-
gues the interesting hypothesis that inﬂammatory episodes,
that increase HO-1 in nondiabetic rats, when superimposed
onpreexistinghyperglycemia-mediatedstresswouldresultin
the impairment of the burst of HO-1 expression. This con-
tention based on the fact that the HO-1 levels in STZ-EIU-
rats may have been impaired by the high production of re-
active oxygen species and reduced NO availability occurring
in diabetes [5, 14]. The high peroxinitrite levels formed into
the eye may have reduced the NO, thus impairing the HO-1
expression. Actually, NO derived from iNOS enhances HO-1
expression in the tissues [15].
Ciliary bodies of STZ-rats showed higher levels of MPO
activity, a marker used to monitor tissue inﬁltration by PMN
[9], even 48h and 72h after LPS, with respect to nondiabetic
normoglycemic rats subjeted to EIU, in contrast to the low
levels of the protein HO-1 found in the ELISA assay at the
sametimepoints.Interestingly,hemintreatmentshowedless
reduction in MPO levels in STZ-rats as compared with non-
diabetic rats at any time point considered. This latter obser-
vationsupportedbypreviousevidenceindicatingthatinduc-
tion of HO-1 activity results in reduced expression of adhe-
sion molecules, reduced adhesion and migration of leuko-
cytes following an inﬂammatory stimulus [16, 17].
The causal correlation between HO-1 expression follow-
ing EIU and white blood cells recruitment into ciliary bod-
ies was conﬁrmed on local generation of leukocyte activa-
tors, cytokines, and chemokines which are known to pro-
mote leukocyte-endothelium interaction [18]. For this pur-
pose we investigated a cytokine able to increase the adhesive
properties of the endothelial wall [19], and that it is impli-
cated in the pathology associated with experimental uveitis
[2], the IL-1 beta. As chemokine we chose CXCL8 because it
is a chemokine able to recruit neutrophils in rodent species
during experimental inﬂammation [20, 21]. The results of
our study showed that the levels of these two cytokines copy
the trend observed with the MPO activity. In particular,
the reduced HO-1 levels within the ciliary bodies of STZ-
hyperglycemic rats subjected to EIU were mirrored by sig-
niﬁcant increase in both these cytokines with respect to EIU
of nondiabetic rats.
In conclusion, our results demonstrated that streptozot-
ocin-induced hyperglycemic rats had altered HO-1 levels to
counteract LPS-induced ocular inﬂammation in the ICB.
Impairment of this stress-sensitive enzyme increases and
prolongs the inﬂammatory response to EIU. It involves
a local increase of the expression of cytokines, increased
recruitment of PMN and cell damage. Thus in perspective,
pharmacologicalagentsthatreducetheoxidativestressinhy-
perglycemic diabetes may reinforce the HO-1 citoprotection
for preventing uveitis as well as in other ocular pathological
situations.
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